Prescient Therapeutics Limited (ASX:PTX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0580
-0.0010 (-1.69%)
At close: Mar 11, 2026

Prescient Therapeutics Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
9.756.9110.495.912.2616.1
Short-Term Investments
0.020.024.0216.020.020.02
Cash & Short-Term Investments
9.776.9314.5121.9212.2816.12
Cash Growth
16.21%-52.27%-33.78%78.41%-23.79%118.48%
Accounts Receivable
5.74.913.922.581.721.24
Receivables
5.74.913.922.581.721.24
Prepaid Expenses
1.091.060.310.250.240.24
Total Current Assets
16.5612.918.7424.7414.2517.6
Property, Plant & Equipment
0.270.010000
Other Intangible Assets
1.651.651.653.373.373.37
Total Assets
18.4814.5620.3928.1117.6220.97
Accounts Payable
1.133.041.721.780.510.23
Accrued Expenses
0.10.070.220.20.120.07
Short-Term Debt
--0.33--0.17
Other Current Liabilities
-0.050.050.050.180.04
Total Current Liabilities
1.283.162.322.030.810.51
Pension & Post-Retirement Benefits
0.010.010.010.010.050.03
Total Liabilities
1.513.172.332.030.860.54
Common Stock
102.7993.8993.2793.2577.2676.67
Retained Earnings
-87.53-84.07-77.4-69.31-62.45-57.51
Comprehensive Income & Other
1.711.572.192.141.951.26
Shareholders' Equity
16.9711.3918.0726.0816.7620.43
Total Liabilities & Equity
18.4814.5620.3928.1117.6220.97
Total Debt
0.27-0.33--0.17
Net Cash (Debt)
9.56.9314.1821.9212.2815.95
Net Cash Growth
13.42%-51.16%-35.28%78.41%-22.99%120.93%
Net Cash Per Share
0.010.010.020.030.020.03
Filing Date Shares Outstanding
1,052805.32805.32805.27654.32641.05
Total Common Shares Outstanding
1,052805.32805.32805.27654.32641.05
Working Capital
15.289.7416.4222.7113.4417.08
Book Value Per Share
0.020.010.020.030.030.03
Tangible Book Value
15.329.7416.4222.7113.417.06
Tangible Book Value Per Share
0.010.010.020.030.020.03
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.